Standard heart attack drug may raise risk of death for some women, says study

Beta blockers, the standard treatment after a heart attack for the last 40 years, may offer no benefit for heart attack patients and can raise death risk in some women, according to a study that called for a rejig of the standard treatment paradigm.

- IANS

Beta blockers, the standard treatment after a heart attack for the last 40 years, may offer no benefit for heart attack patients and can raise death risk in some women, according to a study that called for a rejig of the standard treatment paradigm. Beta blockers are drugs commonly prescribed for a range of cardiac conditions, including heart attacks. It provides no clinical benefit for patients who have had an uncomplicated myocardial infarction with preserved heart function.

The study published in The New England Journal of Medicine and in the